OGN
Organon & Co
NYSE: OGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$13.34
+0.15% today
Updated 2026-04-29
Market cap
$3.50B
P/E ratio
18.53
P/S ratio
0.56x
EPS (TTM)
$0.72
Dividend yield
2.55%
52W range
$6 – $13
Volume
9.4M
Organon & Co (OGN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.42B | $3.69B | $2.77B | $2.19B | $2.46B | $858.00M | $799.00M | $939.00M | $700.00M |
| Capital expenditures | $86.00M | $101.00M | $92.00M | $278.00M | $488.00M | $427.00M | $261.00M | $351.00M | $162.00M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $56.00M | $56.00M | $41.00M | $40.00M | $59.00M | $75.00M | $101.00M | $105.00M | $77.00M |
| Free cash flow | $3.33B | $3.59B | $2.67B | $1.91B | $1.97B | $431.00M | $538.00M | $588.00M | $538.00M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | $145.00M | $145.00M | $145.00M | $145.00M | $290.00M | $294.00M | $297.00M | $88.00M |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $702.00M | — | — | — | — |